Director, Pricing Strategy (Odro/Linvo) - Hematology

The Director, Pricing & Contracting Strategy will serve as the primary point for the Brand on all pricing matters and is responsible for leading the development of cohesive Global/US launch pricing and contracting strategies for product(s) within the Oncology franchise. This position will lead the development of Global/US pricing guidance and management of ongoing market price proposal approvals and serve as the subject matter expert on pricing trends and practices.

In this role, a typical day might include the following:

Managing the design, development and implementation of the product-specific pricing and contracting strategies. This role requires a deep understanding of traditional and innovative approaches to pricing, contracting and reimbursement of specialty products, including oncology.

Demonstrating strong leadership approach that is evidence-based and employs pragmatic and collaborative problem-solving skills. The position requires a solid understanding of the payer archetypes and the pricing dynamic. Having both EU5 and US knowledge and experience will be a plus.

• Lead the development of Launch pricing strategies for assigned product(s), working cross-functionally and establish pricing and contracting guidance in collaboration with key stakeholders including Global/EU Commercial, Global and International Market Access, and HEOR within Regeneron

• Lead the Pricing research in collaboration with key cross functional stakeholders within Regeneron, to ensure quality and timeliness

• Triangulate research insights with key market inputs as part of the strategy development process, while optimizing overall global P&MA needs

• Work with the ROW Pricing Lead to bridge strategy to execution

• Collaborate with Market Access and HEOR to ensure that appropriate pricing elements are incorporated into the Global Value Dossier, payer value proposition, and objection handler

• Co-lead with Market Access, the development of Payer Negotiation Strategies and Tactics including development of alternative pricing models such as price-volume arrangement, budget CAPS, outcomes based arrangements etc.

• Provide strategic inputs and conduct analytics on market specific price proposals to support the Global Pricing Committee process

• Monitor key P&MA trends proactively and identify implications for the Regeneron portfolio

This job might be for you if you:

• Demonstrated experience with developing launch global pricing strategies, preferably in Hematology / Oncology

• Experience working with multi-disciplinary functions which will include Marketing, Market Access, HEOR, Finance, Trade, etc.

• Solid knowledge of US contracting and Buy & Bill dynamics as well as EU5 payer archetypes and HTA/reimbursement decision processes

• Excellent knowledge of pricing market research tools, methodologies, and analytics including exposure to global price management systems

• Must have strong leadership skills, strategic mindset, and the ability to influence without authority

• Provide price-evolution inputs to Finance and Corporate Strategy to support long-term forecasting and commercial strategic planning

To be considered for this role you should have a Bachelor’s degree; Master’s degree/MBA preferred. Qualified candidates must have a Bachelor’s degree from an accredited college or university in math, economics, business administration, health policy, health economics or other relevant qualification. Advanced business degree (MBA) preferred. 15+ years progressive relevant experience acquired at pharmaceutical/biotech companies, Payer/HTA, or relevant healthcare consultancy companies in a multi-national context: US & EU5 experiences.